Annual Drug Patent Expirations for BALCOLTRA Balcoltra is a drug marketed by Avion Pharms and is included in one NDA. There is one patent protecting this drug. Drug patent litigation…
The post New patent expiration for Avion Pharms drug BALCOLTRA appea…
New patent expiration for Avion Pharms drug BALCOLTRA Read Post »
Annual Drug Patent Expirations for SUTENT Sutent is a drug marketed by Cppi Cv and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Cppi Cv drug SUTENT appeared first on DrugPatentWa…
Annual Drug Patent Expirations for CAPRELSA Caprelsa is a drug marketed by Genzyme Corp and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Genzyme Corp drug CAPRELSA appeared first …
New patent expiration for Genzyme Corp drug CAPRELSA Read Post »
CAPRELSA (vandetanib) Genzyme corp Patent: 7,173,038 Expiration: Aug 14, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Pate…
Drug Patent Expirations for the Week of August 8, 2021 Read Post »
Annual Drug Patent Expirations for RIOMET Riomet is a drug marketed by Ranbaxy and Sun Pharm and is included in two NDAs. It is available from one supplier. There are…
The post New patent expiration for Ranbaxy drug RIOMET appeared first on DrugPatentW…
Annual Drug Patent Expirations for STIOLTO+RESPIMAT Stiolto Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are fourteen…
The post New patent expiration for Boehringer Ingelheim d…
New patent expiration for Boehringer Ingelheim drug STIOLTO RESPIMAT Read Post »
Annual Drug Patent Expirations for COMBIVENT+RESPIMAT Combivent Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are seven…
The post New patent expiration for Boehringer Ingelheim …
New patent expiration for Boehringer Ingelheim drug COMBIVENT RESPIMAT Read Post »
Annual Drug Patent Expirations for STRIVERDI+RESPIMAT Striverdi Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are fourteen…
The post New patent expiration for Boehringer Ingelhe…
New patent expiration for Boehringer Ingelheim drug STRIVERDI RESPIMAT Read Post »
Annual Drug Patent Expirations for FLONASE+SENSIMIST+ALLERGY+RELIEF Flonase Sensimist Allergy Relief is a drug marketed by Glaxosmithkline Cons and is included in one NDA. It is available from one supplier. There…
The post New patent expiration for Gla…
New patent expiration for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF Read Post »
Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Glaxo Grp drug BREO ELLIPTA appeared first on…
New patent expiration for Glaxo Grp drug BREO ELLIPTA Read Post »